HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2026, 28: 245-250

Heroin addiction masked by recurrent alcohol and benzodiazepine use: sustained stabilisation following reintroduction of buprenorphine. A case report

Monica Mizza, and Matteo Pacini

Digital Object Identifier:
https://doi.org/10.62401/2531-4122-2026-29

Summary: Background: Recurrent alcohol and benzodiazepine use in patients with previous heroin addiction may be treated as an isolated problem, leaving the underlying opioid-related disorder insufficiently addressed. Recognising this longitudinal pattern can change the therapeutic strategy even when current opioid tolerance is low or absent. Case presentation: A 36-year-old woman presented after alcohol detoxification, with a history of daily intravenous heroin use, inconsistent adherence to previous buprenorphine treatment and repeated increases in alcohol and benzodiazepine use during periods without heroin. Reassessment led to a formulation of incompletely stabilised heroin addiction presenting through non-opioid substance use, with associated bipolar-spectrum vulnerability. Buprenorphine was reintroduced at 2 mg/day and reduced to 1 mg/day after sedation, consistent with the clinical assessment of low opioid tolerance. Sodium oxybate was used only for alcohol detoxification and then discontinued; valproate 500 mg/day was maintained. Full clinical stabilisation was achieved by one month. By this assessment, alcohol-specific pharmacotherapy had been withdrawn. Buprenorphine remained at 1 mg/day, and the patient remained clinically stable without reported substance-use relapses for approximately one year. She subsequently stopped attending and was lost to follow-up. Conclusions: The clinical value of this case lies in recognising a previous heroin-related disorder when recurrent alcohol and benzodiazepine use dominate the presentation. Reintroducing opioid agonist treatment, tailored to current tolerance, was associated with sustained stabilisation after withdrawal of alcohol-specific medication. The case supports considering this formulation in selected patients whose recurrent non-opioid substance use has not been durably controlled by substance-specific interventions.

Keywords: Heroin Addiction; Opioid Use Disorder; Alcohol; Benzodiazepines; Buprenorphine; Maintenance Treatment; Bipolar Spectrum

 

EUROPAD - European Opiate Addiction Treatment Association
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page